221 related articles for article (PubMed ID: 36287138)
1. The metabolic syndrome and its components as prognostic factors in colorectal cancer: A meta-analysis and systematic review.
Lu B; Qian JM; Li JN
J Gastroenterol Hepatol; 2023 Feb; 38(2):187-196. PubMed ID: 36287138
[TBL] [Abstract][Full Text] [Related]
2. Association between metabolic syndrome and its components and incident colorectal cancer in a prospective cohort study.
Tran TT; Gunathilake M; Lee J; Kim J
Cancer; 2022 Mar; 128(6):1230-1241. PubMed ID: 34762301
[TBL] [Abstract][Full Text] [Related]
3. The association of Metabolic Syndrome and its Components with the Incidence and Survival of Colorectal Cancer: A Systematic Review and Meta-analysis.
Han F; Wu G; Zhang S; Zhang J; Zhao Y; Xu J
Int J Biol Sci; 2021; 17(2):487-497. PubMed ID: 33613107
[No Abstract] [Full Text] [Related]
4. The Effect of Metabolic Syndrome on Colorectal Cancer Prognosis after Primary Surgery.
Tao W; Yuan C; Kang B; Liu XY; Cheng YX; Zhang B; Wei ZQ; Peng D
Nutr Cancer; 2023; 75(1):331-338. PubMed ID: 35976038
[TBL] [Abstract][Full Text] [Related]
5. Association between metabolic syndrome and colorectal cancer incidence and all-cause mortality: a hospital-based observational study.
Chung KC; Juang SE; Chen HH; Cheng KC; Wu KL; Song LC; Lee KC
BMC Gastroenterol; 2022 Nov; 22(1):453. PubMed ID: 36368935
[TBL] [Abstract][Full Text] [Related]
6. Abdominal obesity, glucose intolerance and decreased high-density lipoprotein cholesterol as components of the metabolic syndrome are associated with the development of colorectal cancer.
Choi YJ; Lee DH; Han KD; Shin CM; Kim N
Eur J Epidemiol; 2018 Nov; 33(11):1077-1085. PubMed ID: 30196334
[TBL] [Abstract][Full Text] [Related]
7. The combined effect of non-alcoholic fatty liver disease and metabolic syndrome on colorectal carcinoma mortality: a retrospective in Chinese females.
Chen ZF; Dong XL; Huang QK; Hong WD; Wu WZ; Wu JS; Pan S
World J Surg Oncol; 2018 Aug; 16(1):163. PubMed ID: 30097069
[TBL] [Abstract][Full Text] [Related]
8. Systematic review and meta-analysis: Associations between metabolic syndrome and colorectal neoplasia outcomes.
Lu L; Koo S; McPherson S; Hull MA; Rees CJ; Sharp L
Colorectal Dis; 2022 Jun; 24(6):681-694. PubMed ID: 35156283
[TBL] [Abstract][Full Text] [Related]
9. The relationship between metabolic syndrome and the incidence of colorectal cancer.
Lee J; Lee KS; Kim H; Jeong H; Choi MJ; Yoo HW; Han TH; Lee H
Environ Health Prev Med; 2020 Feb; 25(1):6. PubMed ID: 32075578
[TBL] [Abstract][Full Text] [Related]
10. The obesity paradox in patients with colorectal cancer: a systematic review and meta-analysis.
Li Y; Li C; Wu G; Yang W; Wang X; Duan L; Niu L; Chen J; Zhang Y; Zhou W; Liu J; Hong L; Fan D
Nutr Rev; 2022 Jun; 80(7):1755-1768. PubMed ID: 35182150
[TBL] [Abstract][Full Text] [Related]
11. Association Between Metabolic Syndrome and the Risk of Colorectal Cancer Diagnosed Before Age 50 Years According to Tumor Location.
Jin EH; Han K; Lee DH; Shin CM; Lim JH; Choi YJ; Yoon K
Gastroenterology; 2022 Sep; 163(3):637-648.e2. PubMed ID: 35643169
[TBL] [Abstract][Full Text] [Related]
12. Associations of metabolic syndrome and C-reactive protein with mortality from total cancer, obesity-linked cancers and breast cancer among women in NHANES III.
Gathirua-Mwangi WG; Song Y; Monahan PO; Champion VL; Zollinger TW
Int J Cancer; 2018 Aug; 143(3):535-542. PubMed ID: 29488212
[TBL] [Abstract][Full Text] [Related]
13. Metabolic syndrome and colorectal adenoma risk: A systematic review and meta‑analysis.
Wu H; Zhang J; Zhou B
Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101749. PubMed ID: 34214702
[TBL] [Abstract][Full Text] [Related]
14. The Association Between Metabolic Syndrome and Colorectal Cancer Risk by Obesity Status in Korean Women: A Nationwide Cohort Study.
Moon SG; Park B
J Prev Med Public Health; 2022 Sep; 55(5):475-484. PubMed ID: 36229910
[TBL] [Abstract][Full Text] [Related]
15. Effect of metabolic syndrome and its components on survival in colorectal cancer: a prospective study.
Ahmadi A; Noroozi M; Pourhoseingholi MA; Hashemi-Nazari SS
J Renal Inj Prev; 2015; 4(1):15-9. PubMed ID: 25848641
[TBL] [Abstract][Full Text] [Related]
16. Interaction of smoking and metabolic syndrome in increasing the recurrence risk of colorectal cancer in a Chinese male cohort: a retrospective study.
Chen DZ; Ji FY; Xu QM; Wu XX; Cai C; Zhang LJ; Li LJ
Sci Rep; 2018 Jan; 8(1):972. PubMed ID: 29343809
[TBL] [Abstract][Full Text] [Related]
17. Risk of Death in Colorectal Cancer Patients with Multi-morbidities of Metabolic Syndrome: A Retrospective Multicohort Analysis.
Feng Q; Xu L; Li L; Qiu J; Huang Z; Jiang Y; Wen T; Lu S; Meng F; Shu X
Cancer Res Treat; 2021 Jul; 53(3):714-723. PubMed ID: 33285055
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of three endothelial nitric oxide synthase (eNOS) polymorphisms and metabolic syndrome (MetS) in patients with colorectal cancer.
Ko EJ; Kim EJ; Cho HJ; Oh J; Park HS; Ryu CS; Kim JO; Jun HH; Chong SY; Kim JW; Kim NK
Genes Genomics; 2022 Jun; 44(6):659-670. PubMed ID: 35377131
[TBL] [Abstract][Full Text] [Related]
19. Metabolic syndrome and liver-related events: a systematic review and meta-analysis.
Ren H; Wang J; Gao Y; Yang F; Huang W
BMC Endocr Disord; 2019 Apr; 19(1):40. PubMed ID: 31023282
[TBL] [Abstract][Full Text] [Related]
20. Metabolic syndrome and the risk of colorectal cancer: a systematic review and meta-analysis.
Shen X; Wang Y; Zhao R; Wan Q; Wu Y; Zhao L; Wu X
Int J Colorectal Dis; 2021 Oct; 36(10):2215-2225. PubMed ID: 34331119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
